Efficacy of a food plant-based oral cholera toxin B subunit vaccine

Nature Biotechnology

Volumn 16, Issue 3, 1998, Pages 292-297

  Arakawa, Takeshi ^a   Chong, Daniel K X ^a   Langridge, William H R ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agricultural biotechnology; Mucosal antibodies; Vaccine design

Indexed keywords

CHOLERA TOXIN B SUBUNIT; TOXIN ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHEMOLUMINESCENCE; CHOLERA; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD; GENETIC ENGINEERING; IMMUNIZATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; POTATO; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSGENIC PLANT; VERO CELL;

ANIMALS; ANTIBODIES; CERCOPITHECUS AETHIOPS; CHOLERA; CHOLERA TOXIN; DIARRHEA; FEMALE; G(M1) GANGLIOSIDE; IMMUNE SERA; MICE; MICE, INBRED STRAINS; MUCOUS MEMBRANE; PLANTS, GENETICALLY MODIFIED; SOLANUM TUBEROSUM; VACCINES; VERO CELLS;

EID: 0031935290     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0398-292     Document Type: Article

References (36)

1. Holmgren, J. and Svennerholm, A.-M. 1996. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea, pp. 241-253 in Mucosal vaccines. Kiyono, H., Ogra, P.L., McGhee, J.R. (eds.), Academic Press, San Diego.
2. Finkelstein, R.A. 1995. Why do we not yet have a suitable vaccine against cholera? Adv. Exp. Med. Biol. 371B:1633-1640.
3. Mekalanos, J.J. and Sadoff, J.C. 1994. Cholera vaccines: fighting an ancient scourge. Science 265:1337-1389.
4. Waldor, M.K. and Mekalanos, J.J. 1996. Progress toward live-attenuated cholera vaccines. 229-240 in Mucosal vaccines. Kiyono, H., Ogra, P.L., McGhee, J.R. (eds.), Academic Press, San Diego.
5. Mason, H.S., Ball, J.M., Shi, J.-J., Jiang, X., Estes, M.K., and Arntzen, C.J. 1996. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93:5335-5340.
6. Haq, T.A., Mason, H.S., Clements, J.D., and Arntzen, C.J. 1995. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714-716.
7. Thanavala, Y., Yang, Y.-F., Lyons, P., Mason, H.S., and Arntzen, C. 1995. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 92:3358-3361.
8. Mason, H.S. and Arntzen, C.J. 1995. Transgenic plants as vaccine production systems. Trends in Biotechnology 13:388-392.
9. Fujita, K. and Finkelstein, R.A. 1972. Antitoxic immunity in experimental cholera: comparison of immunity induced perorally and parenterally in mice. J. Infect. Dis. 125:647-655.
10. Elson, C.O. and Ealding, W. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736-2741.
11. Lycke, N., Lindholm, L., and Holmgren, J. 1983. IgA isotype restriction in the mucosal but not in the extramucosal immune response after oral immunizations with cholera toxin or cholera B subunit. Int. Arch. Allergy Appl. Immunol. 72:119-127.
12. Arakawa, T., Chong, D.K.X., Merritt, J.L., and Langridge, W.H.R. 1997. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res. 6:403-413.
13. Jackson, R.J., Fujihashi, K., Kiyono, H., and McGhee, J.R. 1996. Luminometry: a novel bioluminescent immunoassay enhances the quantitation of mucosal and systemic antibody responses. J. Immunol. Methods 190:189-197.
14. Apter, F.M., Lender, W.I., Finkelstein, R.A., Mekalanos, J.J., and Neutra, M.R. 1993. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Infect. Immun. 61:5271-5278.
15. de Vos, T. and Dick, T.A. 1991. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. Immunol. Methods 141:285-288.
16. Dertzbaugh, M.T. and Elson C.O. 1993. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Infect. Immun. 61:384-390.
17. Svennerholm, A.M., Jertborn, M., Gothefors, L., Karim, A.M.M.M., Sack, D.A., and Holmgren, J. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:884-893.
18. Jertborn, M. Svennerholm, A.M., and Holmgren, J. 1986. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 24:203-209.
19. Lycke, N., Bromander, A., and Holmgren, J. 1989. Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge. Int. Arch. Allergy Appl. Immunol. 88:273-279.
20. Clemens, J.D., van Loon, F., Sack, D.A., Chakraborty, J., Rao, M.R., Ahmed F., et al. 1991. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J. Infect. Dis. 163:1235-1242.
21. Clemens, J.D., Sack, D.A., Rao, M.R., Chakraborty, J., Khan, M.R., Kay, B., et al. 1992. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area. J. Infect. Dis. 166:1029-1034.
22. Levine, M.M., Kaper, J.B., Black, R.E., and Clements, M.L. 1983. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:510-550.
23. Levine, M.M., Nalin, D.R., Craig, J.P., Hoover, D., Bergquist, E.J., Waterman, D., et al. 1979. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans. R. Soc. Trop. Med. Hyg. 73:3-9.
24. Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J.S., Burlein, J., et al. 1997. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276:607-611.
25. Svennerholm, L. 1976. Interaction of cholera toxin and ganglioside G(M1). Adv. Exp. Med. Biol. 71:191-204.
26. Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M., and Holmgren, J. 1989. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57:1072-1077.
27. Dertzbaugh, M.T. and Elson, C.O. 1993. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 61:48-55.
28. Holmgren, J., Czerkinsky, C., Lycke, N., and Svennerholm, A.-M. 1994. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am. J. Trop. Med. Hyg. 50:42-54.
29. Bergerot, I., Ploix, C., Petersen, J., Moulin, V., Rask, C., Fabien, N., et al. 1997. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:4610-4614.
30. Sun, J.-B., Rask, C., Olsson, T., Holmgren, J., and Czerkinsky, C. 1996. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93:7196-7201.
31. Sun, J.-B., Holmgren, J., and Czerkinsky, C. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91:10795-10799.
32. Koncz, C., Olsson, O., Langridge, W.H.R., Schell, J., and Szalay, A.A. 1987. Expression and assembly of functional bacterial luciferase in plants. Proc. Natl. Acad. Sci. USA 84:131-135.
33. Stavric, S., Speirs, J.I., Konowalchuk, J., and Jeffrey, D. 1978. Stimulation of cyclic AMP secretion in Vero cells by enterotoxins of Escherichia coli and Vibrio cholerae. Infect. Immun. 21:514-517.
34. Punyashthiti, K. and Finkelstein, R.A. 1971. Enteropathogenicity of Escherichia coli. Evaluation of mouse intestinal loops. Infect. Immun. 4:473-478.
35. Escher, A., O'Kane, D.J., Lee, J., and Szalay. A.A. 1989. Bacterial luciferase alpha-beta fusion protein is fully active as a monomer and highly sensitive in vivo to elevated temperature. Proc. Natl. Acad. Sci. USA 86:6528-6532.
36. Langridge, W.H.R., Fitzgerald, K.L., Koncz, C., Schell, J., and Szalay, A.A. 1989. Dual promoter of Agrobacterium tumefaciens mannopine synthase gene is regulated by plant growth hormones. Proc. Natl. Acad. Sci. USA 86:3219-3223.